News

Javara will employ and embed clinical research professionals within NVHC clinics.

Collaboration aims to utilize AI to generate text specifically tailored for creating plain language summary documents.

"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals at DIA 2023.

Solutions will expand outreach of Massive Bio's cancer clinical trials.

Platform provides space for clinical trial participants, caregivers, and health professionals to share their unique experiences in clinical trials and influence change.

In this Q&A, David Esposito, CEO of ONL Therapeutics provides a glimpse into the company's mission, challenges, and strategies associated with clinical trials.

New platform is designed to advance treatments for scleroderma and to identify those agents that should progress from Phase IIb to Phase III clinical trials.

Carebox to help LCRF patients, caregivers, and healthcare professionals to identify relevant lung cancer trials.

AI will be integrated within TTUHSC's EMR system.

Newly acquired eClinical technology suite will be integrated with Sitero's existing Mentor platform with plans to invest in AI.

Case study shows how one CRO ensured high-quality, consistent data in a difficult therapeutic area.

Latest number of autoimmune clinical trials from ClinicalTrials.gov.

A look at the complexities—and potentially conflicting goals—in industry’s commitment to trial-result transparency.

Partnership will utilize the InSilicoTrials' platform and leverage its InSilicoNEURO suite.

Artificial intelligence may find a home in clinical trials and manufacturing in the coming years, but privacy, cyber security, and determining who owns the intellectual properties could pose challenges.

AMCR will bring experience in metabolic, endocrine, and medical device research to Headlands' clinical research site network.

Through TrialHub's data intelligence gathering platform, EmVenio will be able to identify optimal markets to attract clinical trial participants.

Award candidates and winners to be presented on October 26, 2023, at the Prix Galien USA Forum in NYC.

Research initiative has successfully gathered data on pulmonary fibrosis and interstitial lung disease with more than 1,600 participants.

Designed to facilitate and advance the use of complex adaptive, Bayesian, and other novel clinical trial designs, the program provides an opportunity for sponsors to interact with experts from FDA.

Common advice for OA sufferers is joint replacement, but other options are on the horizon.

EMA seeks to define the scientific principles relevant to using AI or machine learning in support of drug development.

Data transfer technology from IgniteData finds 100% of data from vital signs and lab data were successful.

Eko CORE 500™ digital stethoscope will be incorporated into Z1608 solution under development for heart failure patients built on Welldoc's digital therapeutic platform.

In support of the recent ARPA-H NITRO OA Cure Moonshot, the online resources identifies major OA treatment trials and allows patients to sign up.

Enhancements to the new edition support pharma and CROs to increase diversity in clinical trials, as well as align recruitment with disease incidence

Acquisition adds more than 120 team members in India with expertise in biometrics and medical writing.

The agency proposes significant revisions to oversight programs for drugs and medical products.